Your browser doesn't support javascript.
loading
Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling.
Eadie, Laura N; Rehn, Jacqueline A; Schutz, Caitlin E; Heatley, Susan L; Kutyna, Monika M; Hiwase, Devendra K; White, Deborah L; Yeung, David T.
Afiliação
  • Eadie LN; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Rehn JA; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
  • Schutz CE; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Heatley SL; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
  • Kutyna MM; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Hiwase DK; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • White DL; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
  • Yeung DT; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Br J Haematol ; 203(2): 282-287, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37519213
ABSTRACT
Donor-derived haematological neoplasms, in which recipients present with haematological malignancies that have evolved from transplant donor stem cells, have previously been described for myelodysplastic syndrome, myeloproliferative neoplasms, acute myeloid leukaemia and less often, leukaemias of lymphoid origin. Here we describe a rare and complex case of donor-derived T-cell acute lymphoblastic leukaemia with a relatively short disease latency of less than 4 years. Through genomic and in vitro analyses, we identified novel mutations in NOTCH1 as well as a novel activating mutation in STAT5B; the latter targetable with the clinically available drugs, venetoclax and ruxolitinib.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células T Precursoras Limite: Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células T Precursoras Limite: Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália